ALTSTATION.IO

Eastman Chemical Company (EMN) Stock Analysis

By Nova Skye | AltStation.io | Updated February 07, 2026

Price

$77.72

Change

+2.16%

Market Cap

$8.87B

Avg Volume

1.7M

Company Overview

Eastman Chemical Company, based in Kingsport, Tennessee, produces specialty materials used across various industries. Their offerings include additives and functional products like surfactants and solvents, advanced materials such as copolyesters and films, and chemical intermediates for numerous applications. Eastman’s products serve diverse markets including transportation, personal care, agriculture, and electronics. This broad customer base stabilizes their revenue streams by reducing dependency on any single sector.

Eastman is a solid player in the specialty chemicals sector, competing alongside giants like Dow and BASF. They carve out a competitive edge through innovation and a wide product range, particularly in sustainable solutions that appeal to eco-conscious consumers. However, increased regulatory pressures and raw material price volatility pose ongoing threats. The demand for environmentally friendly products is rising, but Eastman must navigate these challenges to maintain its market position.

Currently, Eastman is shifting its focus towards sustainability and innovation. The company recently announced plans to invest over $1 billion in sustainable technology, aiming to improve its product offerings while reducing environmental impact. Despite facing some headwinds, Eastman shows resilience with steady revenue growth and a commitment to strategic advancements. Their proactive approach in addressing market challenges sets the stage for future expansion.

Key Financials

Market Cap

$8.87B

Revenue

$8.75B

EBITDA

$1.47B

Gross Margin

21.1%

Profit Margin

5.4%

Revenue Growth

-12.1%

Total Cash

$489.00M

Total Debt

$5.21B

Free Cash Flow

N/A

52-Week Price Performance Analysis

Price Statistics

P/E Ratio

18.96

Forward P/E

11.55

Beta

1.23

52-Week High

$103.82

52-Week Low

$56.11

EPS

$4.10

50-Day Avg

$65.91

200-Day Avg

$69.23

Price/Book

1.54

Technical Analysis

Over the past year, Eastman Chemical Company (EMN) has experienced a downward trend, declining 18.2% from its previous peak near $99 in February to the current price of $77.72. There is clear support at approximately $70, which has held during previous price declines, while resistance is indicated around the $90 mark, with the stock struggling to break above this level consistently. A notable double bottom formation is apparent, indicating a potential reversal in trend, especially after the recent price surge from late December through January. Recent momentum has shown bullish characteristics, with the price moving upward over the past few weeks, attempting to test the resistance near $80 again. Currently, EMN’s price sits near the higher end of its 52-week range, signaling potential for a continued rebound if upward momentum persists. This positioning above $70 but below $80 suggests careful management of trades as the stock navigates key resistance levels.

Recent News and Developments

Market Update

Here’s a summary of the latest news and developments for Eastman Chemical Company (EMN) stock in the past week:

1. JPMorgan Chase & Co. Raises Price Target Following Earnings Report

On February 2, 2026, JPMorgan Chase & Co. increased its price target for Eastman Chemical (EMN) from $60.00 to $70.00, while maintaining an “overweight” rating on the stock. This adjustment came despite the company slightly missing its quarterly EPS and reporting a 12.1% year-over-year decrease in revenue for the fourth quarter of 2025.

2. Q4 2025 Earnings Slightly Miss Estimates, Q1 2026 Guidance Provided

Eastman Chemical released its fourth-quarter 2025 earnings on January 29, 2026, reporting adjusted earnings of $0.75 per share, which slightly missed the consensus estimate of $0.76. Revenue for the quarter was $1.97 billion, falling short of the $2.03 billion analyst estimate, primarily due to lower volumes and selling prices in a challenging market. Looking ahead to the first quarter of 2026, the company anticipates adjusted earnings per share between $1.00 and $1.20, driven by expected growth in volume/mix and reduced customer inventory actions.

Market Sentiment and Analyst Recommendations

Bull Case

EMN is trading at 18.96x P/E while guiding Q1 2026 earnings to $1.00-$1.20 per share, which would annualize to $4.00-$4.80 and imply a forward multiple closer to 16-19x. JPMorgan just raised its target from $60 to $70, and 16 analysts maintain a buy rating despite recent weakness. The company is executing $125-$150 million in cost cuts plus an additional $50-$100 million from the ETP project, which should meaningfully improve Fibers segment profitability. Q1 guidance signals a recovery narrative: volumes are stabilizing, customer destocking is ending, and the company expects sequential margin expansion. The stock is up 38% from its January lows and has established clear support at $70, suggesting institutional accumulation. At $77.72, you’re buying a turnaround story in a cyclical business at reasonable multiples with concrete near-term catalysts.

Bear Case

Revenue dropped 12.1% year-over-year in Q4, and the company just missed both EPS and revenue estimates despite being in its own guidance range. The debt load of $5.21 billion against $489 million in cash is concerning for a cyclical chemical company facing demand headwinds. The stock peaked at $103.82 just a year ago and is still down 25% from that level, which means the market is pricing in real structural challenges, not just temporary softness. Analyst targets range wildly from $67 to $100, suggesting significant disagreement about fair value. RBC’s January downgrade to sector perform reflects legitimate concerns about execution risk on the ETP project and the durability of any cost savings. If volumes don’t recover as fast as guidance implies, or if the chemical cycle turns uglier, this company’s leverage becomes a real problem.

What to Watch

Track Q1 2026 earnings when reported in late April, specifically whether the company hits the $1.00-$1.20 EPS guidance and whether volume/mix improvements actually materialized. Monitor the Fibers segment margins quarter-to-quarter; any deterioration would signal the ETP project isn’t working. Watch for updates on the $125-$150 million cost reduction program and whether the company achieves those targets on schedule. The $90 resistance level is critical on the chart; a sustained breakout above $90 would suggest the turnaround narrative is gaining traction, while a drop back through $70 would invalidate the bull case. Pay attention to chemical industry demand indicators and customer commentary on inventory levels in earnings calls, since the recovery thesis depends entirely on end-market stabilization. Finally, monitor leverage metrics; if debt-to-EBITDA stays above 3x through 2026, refinancing risk becomes a real concern.

Analyst Consensus

BUY

Based on 16 analyst opinions

Low Target

$67.00

Mean Target

$76.25

High Target

$100.00

Earnings and Financial Data

Sector

Basic Materials

Industry

Specialty Chemicals

Employees

13,000

Earnings & Dividends

Next Earnings

Apr 23, 2026

EPS (Trailing)

$4.10

Dividend Yield

442.0%

Payout Ratio

81.2%

Frequently Asked Questions

Is EMN a good stock to buy?

Analysts recommend EMN as a “BUY” with a target price of $76.25. Given its current price of $77.72, the potential upside is limited, but the fundamentals look strong.

What is EMN’s price target?

The average analyst price target for EMN is $76.25. This represents a small downside from its current trading price of $77.72.

Does EMN pay a dividend?

Yes, Eastman Chemical pays a substantial dividend with a yield of 442.0%. This makes it an attractive option for dividend-seeking investors.

What is EMN’s P/E ratio?

EMN’s trailing P/E is 18.96, and its forward P/E sits at 11.55. These ratios suggest the stock is relatively undervalued compared to its earnings potential.

How has EMN’s stock performed over the past year?

EMN’s stock has fluctuated between $56.11 and $103.82 in the last 52 weeks. This signifies volatility, but it has the potential for recovery considering current valuations.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated February 07, 2026.